UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phenol-Explorer 3.0: a major update of the Phenol-Explorer database to incorporate data on the effects of food processing on polyphenol content

Database : the journal of biological databases and curation, 2013-10, Vol.2013, p.bat070-bat070

2013

Volltextzugriff (PDF)

Predictive biomarkers for programmed death-1/programmed death ligand immune checkpoint inhibitors in nonsmall cell lung cancer

Current opinion in oncology, 2016-03, Vol.28 (2), p.122-129

2016

Volltextzugriff (PDF)

AZD9291 in EGFR-mutant advanced non-small-cell lung cancer patients

Future oncology (London, England), 2015-11, Vol.11 (22), p.3069-3081

2015

Volltextzugriff (PDF)

Crizotinib-Resistant ROS1 Mutations Reveal a Predictive Kinase Inhibitor Sensitivity Model for ROS1- and ALK-Rearranged Lung Cancers

Clinical cancer research, 2016-12, Vol.22 (24), p.5983-5991

2016

Volltextzugriff (PDF)

Does perioperative immunotherapy reduce the risk of second primary cancers?

European journal of cancer (1990), 2023-11, Vol.194, p.113355-113355, Article 113355

2023

Volltextzugriff (PDF)

Assessment of Early Laparoscopic Cholecystectomy in Management of Acute Calcular Cholecystitis

QJM : An International Journal of Medicine, 2024-07, Vol.117 (Supplement_1)

2024

Volltextzugriff (PDF)

Circulating Tumor Cells with Aberrant ALK Copy Number Predict Progression-Free Survival during Crizotinib Treatment in ALK -Rearranged Non-Small Cell Lung Cancer Patients

Cancer research (Chicago, Ill.), 2017-05, Vol.77 (9), p.2222-2230

2017

Volltextzugriff (PDF)

Are we ready to escalate or de-escalate immune treatment strategies in NSCLC based on liquid biopsy data?

European journal of cancer (1990), 2023-12, Vol.195, p.113369-113369, Article 113369

2023

Volltextzugriff (PDF)

Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK -Rearranged Non-Small-Cell Lung Cancer

Clinical cancer research, 2019-11, Vol.25 (22), p.6671-6682

2019

Volltextzugriff (PDF)

RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion

Journal of thoracic oncology, 2023-05, Vol.18 (5), p.576-586

2023

Volltextzugriff (PDF)

Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy

Clinical cancer research, 2021-01, Vol.27 (2), p.492-503

2021

Volltextzugriff (PDF)

ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMA

European journal of cancer (1990), 2022-05, Vol.166, p.112-125

2022

Volltextzugriff (PDF)

Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay

PloS one, 2020-06, Vol.15 (6), p.e0234302

2020

Volltextzugriff (PDF)

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry

Journal of clinical oncology, 2017-05, Vol.35 (13), p.1403-1410

2017

Volltextzugriff (PDF)

Small RNAs derived from lncRNA RNase MRP have gene-silencing activity relevant to human cartilage–hair hypoplasia

Human molecular genetics, 2014-01, Vol.23 (2), p.368-382

2014

Volltextzugriff (PDF)

Early-Stage Non-Small Cell Lung Cancer: New Challenges with Immune Checkpoint Blockers and Targeted Therapies

Cancers, 2024-08, Vol.16 (16), p.2779

2024

Volltextzugriff (PDF)

AZD9291 in

Future oncology (London, England), 2015-11, Vol.11 (22), p.3069-3081

2015

Volltextzugriff (PDF)

LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value

Lung cancer (Amsterdam, Netherlands), 2017-10, Vol.112, p.62-68

2017

Volltextzugriff (PDF)

Association of metastatic pattern and molecular status in stage IV non-small cell lung cancer adenocarcinoma

European radiology, 2020-09, Vol.30 (9), p.5021-5028

2020

Volltextzugriff (PDF)

Light-driven control of the composition of a supramolecular network

Chemical communications (Cambridge, England), 2019-04, Vol.55 (30), p.4335-4338

2019

Volltextzugriff (PDF)

Circulating Tumor DNA Analysis for Patients with Oncogene-Addicted NSCLC With Isolated Central Nervous System Progression

Journal of thoracic oncology, 2020-03, Vol.15 (3), p.383-391

2020

Volltextzugriff (PDF)

Chemical signal cascading in a supramolecular network

Chemical communications (Cambridge, England), 2020-04, Vol.56 (26), p.3737-374

2020

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(109)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(64)
Life Sciences & Biomedicine
(54)
Oncology
(32)
Humans
(31)
Life Sciences
(16)
Male
(15)
Female
(13)
Middle Aged
(12)
Aged
(11)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(11)
Lung Neoplasms - Drug Therapy
(11)
Lung Neoplasms - Genetics
(11)
Adult
(8)
Carcinoma, Non-Small-Cell Lung - Genetics
(8)
Lung Cancer
(8)
Nsclc
(8)
Respiratory System
(8)
Immunotherapy
(7)
Treatment Outcome
(7)
Cancer
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A Framework for Cognitive, Decentralized Container Orchestration

Phenol-Explorer 3.0: a major update of the Phenol-Explorer database to incorporate data on the effects of food processing on polyphenol content

Predictive biomarkers for programmed death-1/programmed death ligand immune checkpoint inhibitors in nonsmall cell lung cancer

AZD9291 in EGFR-mutant advanced non-small-cell lung cancer patients

Crizotinib-Resistant ROS1 Mutations Reveal a Predictive Kinase Inhibitor Sensitivity Model for ROS1- and ALK-Rearranged Lung Cancers

Does perioperative immunotherapy reduce the risk of second primary cancers?

Assessment of Early Laparoscopic Cholecystectomy in Management of Acute Calcular Cholecystitis

Circulating Tumor Cells with Aberrant ALK Copy Number Predict Progression-Free Survival during Crizotinib Treatment in ALK -Rearranged Non-Small Cell Lung Cancer Patients

Are we ready to escalate or de-escalate immune treatment strategies in NSCLC based on liquid biopsy data?

Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK -Rearranged Non-Small-Cell Lung Cancer

RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion

Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer

Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy

ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMA

Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay

Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry

Small RNAs derived from lncRNA RNase MRP have gene-silencing activity relevant to human cartilage–hair hypoplasia

Early-Stage Non-Small Cell Lung Cancer: New Challenges with Immune Checkpoint Blockers and Targeted Therapies

AZD9291 in

LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value

Association of metastatic pattern and molecular status in stage IV non-small cell lung cancer adenocarcinoma

Light-driven control of the composition of a supramolecular network

Circulating Tumor DNA Analysis for Patients with Oncogene-Addicted NSCLC With Isolated Central Nervous System Progression

Chemical signal cascading in a supramolecular network

Suchergebnisse filtern